Document is current
Any future updates will be listed below
-
Authors
Uhlmann, Erik J.
Mackel, Charles E.
Deforzh, Evgeny
Rabinovsky, Rosalia
Brastianos, Priscilla K.
Varma, Hemant
Vega, Rafael A.
Krichevsky, Anna M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01CA215072)
- License Information
-
More Information
Article History
Received: 16 January 2023
Accepted: 8 February 2023
First Online: 21 February 2023
Declarations
:
: EJU, CEM, ED, RR, HV, RAV, AMK declared no conflict of interest. PKB has consulted for Angiochem, Genentech/Roche, Lilly, Tesaro, ElevateBio, Pfizer (Array), Dantari, SK Life Sciences, Advise Connect Inspire (ACI), Voyager Therapeutics and Sintetica, and has received grant/research support for MGH from Merck, Bristol Myers Squibb, Mirati Therapeutics, and Lilly and honoraria from Merck, Genentech/Roche, Pfizer, and Lilly.
: Meningioma specimens were obtained from patients wishing to participate in the study and signed informed consent using a protocol approved by the Institutional Review Board, and in accordance with Good Clinical Practice guidelines.
: Informed consent was obtained from all individual participants included in the study and all written consent forms were submitted to the Institutional Review Board.
: This manuscript contains no protected health information of any of the individual participants.
